LP
FLNA

LMR Partners’s Filana Therapeutics FLNA Stock Holding History

LMR Partners’s Portfolio FLNA Stock Details FLNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-20,000
Closed -$30K – 1621
2025
Q1 		$30K Sell
20,000
-475,400
-96% -$1.2M ﹤0.01% 1219
2024
Q4 		$1.17M Buy
495,400
+84,400
+21% +$1.48M 0.01% 708
2024
Q3 		$12.1M Buy
411,000
+212,600
+107% +$4.9M 0.1% 185
2024
Q2 		$2.45M Buy
198,400
+2,800
+1% +$59K 0.02% 500
2024
Q1 		$3.97M Sell
195,600
-160,000
-45% -$3.69M 0.04% 390
2023
Q4 		$8M Buy
355,600
+297,600
+513% +$6.29M 0.09% 223
2023
Q3 		$965K Buy
58,000
+28,400
+96% +$563K 0.01% 493
2023
Q2 		$726K Buy
+29,600
New +$713K 0.01% 459
2022
Q2 		– Sell
-1,001,500
Closed -$37.2M – 1443
2022
Q1 		$37.2M Sell
1,001,500
-304,000
-23% -$12.9M 0.43% 35
2021
Q4 		$57M Buy
+1,305,500
New +$68.5M 0.58% 22

Other funds holding FLNA

Marshall Wace
Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
GC
GMT Capital Atlanta, Georgia $2.19B AUM 72.3% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Group One Trading
Group One Trading Chicago, Illinois $52.2B AUM 104.56% 1-Year Est. Return

LMR Partners's FLNA Position: Q1 2025 in Review

LMR Partners sold out of Filana Therapeutics (FLNA) in Q1 2025, closing a stake of 161,493 shares — an estimated $408K sold.

LMR Partners first reported a position in FLNA in Q1 2014 and held it in 3 quarters. The position peaked at $381K in Q4 2024. 117 funds tracked by Wall St. Rank hold FLNA as of Q1 2025.

  • LMR Partners reported no remaining Filana Therapeutics position as of Q1 2025 after selling out during the quarter.
  • LMR Partners sold 161,493 Filana Therapeutics shares in Q1 2025, an estimated $408K.
  • LMR Partners first reported a position in Filana Therapeutics in Q1 2014 and held it in 3 quarters.
  • LMR Partners's Filana Therapeutics position peaked at $381K in Q4 2024.
  • 117 funds tracked by Wall St. Rank held Filana Therapeutics as of Q1 2025.

Based on LMR Partners's 13F filing for Q1 2025, filed 15 May 2025.